Search research articles
Contact Us
Filters
Showing results (111-120 of 256) with videos related to
Page
of 26
Sort By:
Best Practice & Research. Clinical Gastroenterology
|
November 30, 2011
Curcumin: the potential for efficacy in gastrointestinal diseases
Glen R B Irving, Ankur Karmokar, David P Berry, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 9, 2003
Molecular biomarkers of colorectal carcinogenesis and their role in surveillance and early intervention
G Garcea, R A Sharma, A Dennison, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 31, 2000
The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease
K J O'Byrne, A G Dalgleish, M J Browning, et al.
The Lancet. Oncology
|
March 21, 2002
Angiogenesis as a biomarker and target in cancer chemoprevention
R A Sharma, A L Harris, A G Dalgleish, et al.
Investigational New Drugs
|
January 1, 1995
Didemnin B in favourable histology non-Hodgkin's lymphoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group
G Goss, A Muldal, R Lohmann, et al.
Cancer Chemotherapy and Pharmacology
|
April 6, 2010
Pharmacokinetics in mice and metabolism in murine and human liver fractions of the putative cancer chemopreventive agents 3',4',5',5,7-pentamethoxyflavone and tricin (4',5,7-trihydroxy-3',5'-dimethoxyflavone)
Hong Cai, Stewart Sale, Robert G Britton, et al.
Molecular Nutrition & Food Research
|
June 1, 2012
Dietary intake of rosmarinic acid by Apc(Min) mice, a model of colorectal carcinogenesis: levels of parent agent in the target tissue and effect on adenoma development
Ankur Karmokar, Timothy H Marczylo, Hong Cai, et al.
International Journal of Cancer
|
December 13, 2007
Multiple end-point analysis reveals cisplatin damage tolerance to be a chemoresistance mechanism in a NSCLC model: implications for predictive testing
Gabriela M Almeida, Tiago L Duarte, Peter B Farmer, et al.
Annals of the New York Academy of Sciences
|
January 26, 2011
Clinical trials of resveratrol
Ketan R Patel, Edwina Scott, Victoria A Brown, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2004
Angiogenesis of gastrointestinal tumours and their metastases--a target for intervention?
G Garcea, T D Lloyd, A Gescher, et al.
Page
of 26
Search research articles
Search
Showing results (111-120 of 256) with videos related to
Sort By:
Page
of 26
Best Practice & Research. Clinical Gastroenterology
|
November 30, 2011
Curcumin: the potential for efficacy in gastrointestinal diseases
Glen R B Irving, Ankur Karmokar, David P Berry, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 9, 2003
Molecular biomarkers of colorectal carcinogenesis and their role in surveillance and early intervention
G Garcea, R A Sharma, A Dennison, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 31, 2000
The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease
K J O'Byrne, A G Dalgleish, M J Browning, et al.
The Lancet. Oncology
|
March 21, 2002
Angiogenesis as a biomarker and target in cancer chemoprevention
R A Sharma, A L Harris, A G Dalgleish, et al.
Investigational New Drugs
|
January 1, 1995
Didemnin B in favourable histology non-Hodgkin's lymphoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group
G Goss, A Muldal, R Lohmann, et al.
Cancer Chemotherapy and Pharmacology
|
April 6, 2010
Pharmacokinetics in mice and metabolism in murine and human liver fractions of the putative cancer chemopreventive agents 3',4',5',5,7-pentamethoxyflavone and tricin (4',5,7-trihydroxy-3',5'-dimethoxyflavone)
Hong Cai, Stewart Sale, Robert G Britton, et al.
Molecular Nutrition & Food Research
|
June 1, 2012
Dietary intake of rosmarinic acid by Apc(Min) mice, a model of colorectal carcinogenesis: levels of parent agent in the target tissue and effect on adenoma development
Ankur Karmokar, Timothy H Marczylo, Hong Cai, et al.
International Journal of Cancer
|
December 13, 2007
Multiple end-point analysis reveals cisplatin damage tolerance to be a chemoresistance mechanism in a NSCLC model: implications for predictive testing
Gabriela M Almeida, Tiago L Duarte, Peter B Farmer, et al.
Annals of the New York Academy of Sciences
|
January 26, 2011
Clinical trials of resveratrol
Ketan R Patel, Edwina Scott, Victoria A Brown, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2004
Angiogenesis of gastrointestinal tumours and their metastases--a target for intervention?
G Garcea, T D Lloyd, A Gescher, et al.
Page
of 26